| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Ofc, COO | Chief Operating Officer | Chief Operating Officer
1 company
Jim Wassil is EVP, Chief Scientific Ofc, COO at PCVX. From January 2021 to October 2026, the filings on record show 0 open-market purchases and 38 sales. Jim Wassil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.8M at current prices.
Our model assigns Jim Wassil a middling insider score of 53/100, based on 31 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -9.0%.
The PCVX filings lean toward selling, a net 179,087 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $73.27 | $586,165.11 | -4.9% | -51.4% | -17.0% | |
| Feb 3, 2025 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $86.22 | $689,790.43 | -3.7% | -59.6% | -34.3% | |
| Jan 2, 2025 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $83.66 | $669,266.91 | -3.7% | -59.6% | -44.2% | |
| Dec 2, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $92.49 | $739,884.53 | -3.7% | -21.3% | -51.2% | |
| Nov 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $106.80 | $854,422.60 | -3.7% | -14.3% | -57.8% | |
| Oct 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 8,000 | $114.24 | $913,917.45 | -3.8% | -29.0% | -67.1% | |
| Sep 16, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 10,000 | $115.96 | $1,159,634.91 | -4.7% | -21.7% | -72.7% | |
| Sep 3, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 10,000 | $111.93 | $1,119,251.67 | -4.6% | -16.8% | -70.9% | |
| Aug 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $78.84 | $236,527.05 | -1.4% | +35.0% | -58.0% | |
| Jul 1, 2024 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 3,000 | $76.34 | $229,012.65 | -1.4% | +48.5% | -57.2% |